IMMUNOGAST: An umbrella phase 2 trial to assess personalized targeted IMMUNOtherapy-based regimens in recurrent advanced/metastatic GASTric adenocarcinoma patients
The IMMUNOGAST study is researching new, tailor-made treatments for advanced stomach (gastric) cancer that has either spread to other parts of the body or returned after previous treatment. This study is exploring different immunotherapy medicines, which work by helping your own immune system fight the cancer. It's a 'Phase II' trial, meaning it's testing if these treatments are safe and effective. Researchers are trying to find out which specific immunotherapy works best for different people, making the treatment more personal. The study is open to adults aged 18 and older, regardless of whether they are male or female, who are looking for new treatment options.
At a glance
What is this study about?
The IMMUNOGAST study is an important research project focused on finding better ways to treat a type of cancer called gastric adenocarcinoma, which is a common form of stomach cancer. This study is specifically for patients whose cancer has spread to other parts of the body (advanced) or has come back after they've already had treatment (recurrent).
What makes IMMUNOGAST different is its 'personalized' approach. This means that instead of a one-size-fits-all treatment, doctors are trying to figure out which specific immunotherapy medicines might work best for each individual patient. Immunotherapy is a type of treatment that uses your body's own immune system to recognise and fight cancer cells, often with fewer side effects than traditional chemotherapy.
This is a 'Phase II' study, which means it's one of the earlier steps in testing new treatments. Doctors are trying to see if these immunotherapy treatments are safe and if they can effectively shrink the cancer or slow its growth. The ultimate goal is to find more effective and gentler treatments for stomach cancer patients.
Key takeaways
- This study is testing new, personalised immunotherapy treatments for advanced stomach cancer.
- It aims to find the best treatment for each individual patient.
- The study is for people whose stomach cancer has spread or come back.
- You would receive close medical care and supervision.
- Participation is voluntary, and you can withdraw at any time.
Who may be eligible?
This study is designed for adults who have been diagnosed with a type of stomach cancer called gastric adenocarcinoma. This specifically applies if the cancer has spread to other parts of your body or has returned after you've already had treatment for it, and your cancer is currently getting worse.
You must be at least 18 years old to take part, and there's no upper age limit. The study is open to both men and women. The research team will need to check your medical history and test results carefully to make sure this is the right study for you, as there might be other specific health conditions or medications that would prevent you from joining.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with stomach cancer (gastric adenocarcinoma)?
- Has your stomach cancer spread or returned after treatment?
- Are you looking for new treatment options for your cancer?
What does participation involve?
If you join the IMMUNOGAST study, you would receive the study medication as prescribed by the research team. This would involve regular visits to the hospital or clinic for treatments, check-ups, and tests like blood tests, scans, and possibly biopsies, to see how you are responding to the treatment and to monitor your health. The specific schedule and duration of these visits would depend on the treatment you receive and how you are feeling. Throughout the study, you would have close medical supervision, and the doctors and nurses would be there to support you and answer any questions you have.
Potential risks and benefits
Locations (1)
- —UnverifiedFrance
Common questions
What kind of cancer is this study for?
This study is for advanced stomach (gastric) cancer that has spread or returned after previous treatment.
What is immunotherapy?
Immunotherapy is a treatment that helps your body's own immune system fight the cancer cells.
Do I have to pay to be in the study?
No, all study-related treatments and tests are provided at no cost to you.
How long does the study last?
The length of your participation can vary depending on the treatment and how you respond. Your doctor will discuss this with you.
Can women take part in this study?
Yes, the study is open to both men and women aged 18 and over.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.